Skip to content

The effect of a tagatose preload on postprandial and whole-day blood glucose levels in adults

The effect of a tagatose preload on postprandial and whole-day blood glucose levels in adults

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102881
Enrollment
Unknown
Registered
2025-05-21
Start date
2025-07-15
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Tagatose preload group:Consuming tagatose 20 minutes before a standardized breakfast comprising white bread and butter
Co-ingestion of tagatose group:Consuming tagatose with a standardized breakfast consisting of white bread and butter
Control group:Consuming glucose with a standardized breakfast consisting of white bread and butter

Sponsors

China Agricultural University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Age>=18 years; 2. No history of food allergies; 3. Able to tolerate fasting for at least 10h; 4. People with normal blood sugar or prediabetes; 5. Voluntarily participate in this trial and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Pregnant women, nursing mothers, patients with tumors and other major diseases; 2. Severe mental illness, such as schizophrenia; 3. Have a history of food allergies; 4. Have a history of diabetes mellitus or have genetic syndromes or diseases known to affect glucose tolerance (such as glucose-6-phosphate dehydrogenase deficiency, polycystic ovary syndrome, etc.); 5. Taking drugs known to affect glucose tolerance (such as thiazide diuretics, glucocorticoids, spironolactone, etc.) in the past 1 month; 6. In the past 1 month, there have been drugs that affect appetite and gastrointestinal function; 7. Have taken antibiotics and probiotics in the past 1 month; 8. Those who are losing weight; 9. Smokers and alcoholics; 10. Those who participate in other clinical trials; 11. Those who are not proficient in operating smartphones; 12. Wearing a continuous glucose meter is not accepted.

Design outcomes

Primary

MeasureTime frame
Blood glucose;

Secondary

MeasureTime frame
Satiety/Appetite score;Adverse event;

Countries

China

Contacts

Public ContactRuixin Zhu

China Agricultural University

zhuruixin07@126.com+86 10 6273 0004

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026